Cargando…
The Time and Place for Nature in Drug Discovery
[Image: see text] The case for a renewed focus on Nature in drug discovery is reviewed; not in terms of natural product screening, but how and why biomimetic molecules, especially those produced by natural processes, should deliver in the age of artificial intelligence and screening of vast collecti...
Autores principales: | Young, Robert J., Flitsch, Sabine L., Grigalunas, Michael, Leeson, Paul D., Quinn, Ronald J., Turner, Nicholas J., Waldmann, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709949/ https://www.ncbi.nlm.nih.gov/pubmed/36465532 http://dx.doi.org/10.1021/jacsau.2c00415 |
Ejemplares similares
-
Chemical
Evolution of Natural Product Structure
por: Grigalunas, Michael, et al.
Publicado: (2022) -
Spacial Score—A
Comprehensive Topological Indicator
for Small-Molecule Complexity
por: Krzyzanowski, Adrian, et al.
Publicado: (2023) -
Fragment-based screening with natural products for novel anti-parasitic disease drug discovery
por: Liu, Miaomiao, et al.
Publicado: (2019) -
Synthesis of Indofulvin Pseudo‐Natural Products Yields a New Autophagy Inhibitor Chemotype
por: Burhop, Annina, et al.
Publicado: (2021) -
Natural product fragment combination to performance-diverse pseudo-natural products
por: Grigalunas, Michael, et al.
Publicado: (2021)